Replies to post #10875 on ANI Pharmaceuticals (ANIP)

[Easka]

Brusselsspirit Thanks for the link. More of a market than I thought for IS,
139M in 2019. It also says in the article that the main 2 competitors Acthar Gel and Sabril both have Orphan Drug Exclusivity in the US.